Researchers classify Alzheimer’s progression and subtypes for a personalized approach to the disease
Published: 29 November 2022
Alzheimer’s disease is a disorder characterized by abnormalities in several different biological areas.
A study carried out by HBHL-funded researcher Yasser Iturria-Medina and his research group, in the Department of Neurology and Neurosurgery at The Neuro, represents the first and largest multimodal data collection effort to date for Alzheimer’s disease.
This work represents the most significant effort so far to classify Alzheimer's disease from a multi-level molecular perspective.
The study’s observations will pave the way to an individually-tailored, multi-system molecular classification of Alzheimer’s disease that may help identify clear targets for preventive treatments or medications.
Read more about this research.